Short answer · Medically reviewed summary · Last updated: 2026-05-08
Carcinoid syndrome is generally not considered an inherited or hereditary condition, as it is a systemic manifestation caused by the release of hormones from neuroendocrine tumors. While most cases are sporadic, rare instances of neuroendocrine tumors can be associated with inherited cancer syndromes, meaning the underlying tumor, rather than carcinoid syndrome itself, may have a genetic component. Is Carcinoid Syndrome considered a hereditary condition? In the vast majority of cases, carcinoid syndrome is not hereditary.
1 people with Carcinoid Syndrome have shared their first-person experience on this question at DiseaseMaps.
Carcinoid syndrome is generally not considered an inherited or hereditary condition, as it is a systemic manifestation caused by the release of hormones from neuroendocrine tumors. While most cases are sporadic, rare instances of neuroendocrine tumors can be associated with inherited cancer syndromes, meaning the underlying tumor, rather than carcinoid syndrome itself, may have a genetic component.
In the vast majority of cases, carcinoid syndrome is not hereditary. It occurs when a neuroendocrine tumor (NET) secretes substances like serotonin into the bloodstream, usually after the tumor has metastasized to the liver. Because carcinoid syndrome is a clinical manifestation of tumor progression, it is not passed down through families in a traditional Mendelian inheritance pattern like autosomal dominant or recessive traits.
While carcinoid syndrome itself is not genetic, clinicians may recommend genetic testing if they suspect the underlying neuroendocrine tumor is part of a hereditary cancer syndrome. Genetic counseling and testing are typically reserved for patients who meet specific clinical criteria, such as:
Carcinoid syndrome is caused by somatic mutations—changes that occur in the DNA of the tumor cells themselves—rather than germline mutations inherited from parents. These somatic mutations are not present in every cell of the body and are not passed on to offspring. De novo, or spontaneous, mutations in tumor cells drive the development of the primary neuroendocrine tumor, which then leads to carcinoid syndrome if left untreated or if it progresses.
Medical disclaimer: This information is for educational purposes only and does not constitute medical advice; always consult with a qualified healthcare provider regarding your specific health condition.